Heregulins implicated in cellular functions other than receptor activation

被引:17
作者
Breuleux, M
Schoumacher, F
Rehn, D
Küng, W
Mueller, H
Eppenberger, U
机构
[1] Stiftung Tumorbank, Dept Res, Mol Tumorbiol Unit, Basel, Switzerland
[2] Univ Clin Med Sch, Basel, Switzerland
关键词
D O I
10.1158/1541-7786.MCR-05-0016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heregulins (HRG) are known as soluble secreted growth factors that, on binding and activating ErbB3 and ErbB4 cell surface receptors, are involved in cell proliferation, metastasis, survival, and differentiation in normal and malignant tissues. Previous studies have shown that some HRG1 splice variants are translocated to the nucleus. By investigating the subcellular localization of HRG alpha(1-241), nuclear translocation and accumulation in nuclear dot-like structures was shown in breast cancer cells. This subcellular distribution pattern depends on the presence of at least one of two nuclear localization sequences and on two domains on the HRG construct that were found to be necessary for nuclear dot formation. Focusing on the nuclear function of HRG, a mammary gland cDNA library was screened with the mature form of HRG alpha in a yeast two-hybrid system, and coimmunoprecipitation of endogenous HRG was done. The data reveal positive interactions of HRG alpha(1-241) with nuclear factors implicated in different biological functions, including transcriptional control as exemplified by interaction with the transcriptional repressor histone deacetylase 2. In addition, HRG alpha(1-241) showed transcriptional repression activity in a reporter gene assay. Furthermore, a potential of HRG proteins to form homodimers was reported and the HRG sequence responsible for dimerization was identified. These observations strongly support the notion that HRG1 splice variants have multifunctional properties, including previously unknown regulatory functions within the nucleus that are different from the activation of ErbB receptor signaling.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 56 条
[1]  
Adam RM, 2003, CANCER RES, V63, P484
[2]   The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions [J].
Alroy, I ;
Yarden, Y .
FEBS LETTERS, 1997, 410 (01) :83-86
[3]  
Atlas E, 2003, MOL CANCER RES, V1, P165
[4]   Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein [J].
Ayi, TC ;
Tsan, JT ;
Hwang, LY ;
Bowcock, AM ;
Baer, R .
ONCOGENE, 1998, 17 (16) :2143-2148
[5]   THE STRUCTURAL BASIS FOR THE SPECIFICITY OF EPIDERMAL GROWTH-FACTOR AND HEREGULIN BINDING [J].
BARBACCI, EG ;
GUARINO, BC ;
STROH, JG ;
SINGLETON, DH ;
ROSNACK, KJ ;
MOYER, JD ;
ANDREWS, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (16) :9585-9589
[6]   Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells [J].
Bhat-Nakshatri, P ;
Sweeney, CJ ;
Nakshatri, H .
ONCOGENE, 2002, 21 (13) :2066-2078
[7]   Heart-type fatty acid binding protein - involvement in growth inhibition and differentiation [J].
Borchers, T ;
Hohoff, C ;
Buhlmann, C ;
Spener, F .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1997, 57 (01) :77-84
[8]   BIOSYNTHETIC PROCESSING OF NEU DIFFERENTIATION FACTOR - GLYCOSYLATION, TRAFFICKING, AND REGULATED CLEAVAGE FROM THE CELL-SURFACE [J].
BURGESS, TL ;
ROSS, SL ;
QIAN, YX ;
BRANKOW, D ;
HU, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19188-19196
[9]   Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases [J].
Carraway, KL ;
Weber, JL ;
Unger, MJ ;
Ledesma, J ;
Yu, N ;
Gassmann, M ;
Lai, C .
NATURE, 1997, 387 (6632) :512-516
[10]   RGS12TS-S localizes at nuclear matrix-associated subnuclear structures and represses transcription: Structural requirements for subnuclear targeting and transcriptional repression [J].
Chatterjee, TK ;
Fisher, RA .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (12) :4334-4345